Brief: Imara Board Approves Reduction Of Co’s Workforce By 83% Across All Areas Of Co, To Total Of 6 Remaining Full-Time Employees

Enliven Therapeutics

14/04/2022 22:24

April 14 (Reuters) - Imara Inc  IMRA.O :
    * IMARA INC - ON APRIL 12, BOARD APPROVED REDUCTION OF CO’S
WORKFORCE BY ABOUT 83% ACROSS ALL AREAS OF CO, TO TOTAL OF 6
REMAINING FULL-TIME EMPLOYEES
    * IMARA INC - WORKFORCE REDUCTION IS EXPECTED TO BE
SUBSTANTIALLY
COMPLETED BY THE END OF THE SECOND QUARTER OF 2022
    * IMARA INC - EXPECTS TO RECORD ONE-TIME RESTRUCTURING
CHARGE OF
ABOUT  $2.0 MILLION  TO $2.2 MILLION IN SECOND QUARTER OF 2022
    * IMARA INC - IN CONNECTION WITH THE WORKFORCE REDUCTION,
KENNETH
ATTIE, CO’S CHIEF MEDICAL OFFICER WILL SEPARATE FROM CO
EFFECTIVE APRIL 20, 2022
    * IMARA INC - ON APRIL 10, BOARD DETERMINED TO DISCONTINUE
DEVELOPMENT OF TOVINONTRINE IN HEART FAILURE WITH PRESERVED
EJECTION FRACTION
    * IMARA INC - ON APRIL 10, BOARD DETERMINED TO DISCONTINUE
COMPANY’S DEVELOPMENT PLANS WITH RESPECT TO IMR-261

Further company coverage:  IMRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))